Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872893 | 1.00 | LMNA (0.52) | LMNALPAR2LPAR3LPAR1THRB | |
| SCHEMBL872892 | 1.00 | LMNA (0.52) | LMNALPAR2LPAR3LPAR1THRB | |
| SCHEMBL3270977 | 0.93 | LMNA (0.39) | LMNALPAR2LPAR3LPAR1 | |
| SCHEMBL3508513 | 0.93 | LMNA (0.39) | LMNALPAR2LPAR3LPAR1 | |
| SCHEMBL27565987 | 0.81 | LMNA (0.50) | LMNA | |
| SCHEMBL16902064 | 0.79 | LPAR2 (0.34) | LPAR2LPAR3LPAR1 | |
| SCHEMBL16902072 | 0.79 | LPAR2 (0.34) | LPAR2LPAR3LPAR1 | |
| SCHEMBL26001345 | 0.78 | LPAR2 (0.47) | LMNALPAR2LPAR3LPAR1NR1I2 | |
| SCHEMBL3673217 | 0.78 | LMNA (0.46) | LMNA | |
| SCHEMBL3673215 | 0.78 | LMNA (0.46) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| EP-4157203-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | Givaudan SA (CH) | 2023-04-05 | — | — | EP | claimed |
| WO-2021239742-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | GIVAUDAN SA (CH) | 2021-12-02 | — | — | WO | claimed |
| EP-3387099-B1 | FOOD CONTACT SURFACE SANITIZING LIQUID | CLOROX CO (US) | 2021-07-21 | — | — | EP | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| US-10113140-B2 | Freshening compositions and devices comprising same | THE PROCTER & GAMBLE COMPANY (US) | 2018-10-30 | — | — | US | claimed |
| US-20180004875-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2018-01-04 | — | — | US | claimed |
| US-20170333591-A9 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2017-11-23 | — | — | US | claimed |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049397-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089318-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089465-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | LMNA 4565/4885LPAR2 3833/4885LPAR3 3096/4885 |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | LMNA 4542/4885LPAR2 3833/4885LPAR3 3041/4885 |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | LMNA 4565/4885LPAR2 3833/4885LPAR3 3096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.